NovaBay Pharmaceuticals Inc (NYSE:NBY) shares are lower by 66% to $0.67 over the trailing five sessions after announcing the pricing of its public offering of 3.2 million shares (or pre-funded ...
In this article, we will be taking a look at the 15 Best Biotech Penny Stocks to Invest in Right Now. NovaBay Pharmaceuticals, Inc. is one of them. NovaBay Pharmaceuticals, Inc. (NYSE:NBY) is a ...
EMERYVILLE, Calif., November 22, 2024--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) ("NovaBay" or the "Company") announces that its Special Meeting of Stockholders held on November 22, 2024 has ...
NovaBay Pharmaceuticals (NBY) is expected to deliver a year-over-year increase in earnings on flat revenues when it reports results for the quarter ended September 2018. This widely-known consensus ...
POINT CAPITAL PARTNERS LP POPLAR, a 10% owner of $NBY, bought 31,703 shares of the company on 01-27-2025 for an estimated $21,875. This trade was reported by Quiver ...
NovaBay Pharmaceuticals shares are trading lower by 61% during Friday's session. The company announced the pricing of its public offering. Want to trade this news? Get access to the 34-0 income ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results